1. Home
  2. AIMD vs BHAT Comparison

AIMD vs BHAT Comparison

Compare AIMD & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • BHAT
  • Stock Information
  • Founded
  • AIMD 1984
  • BHAT 2010
  • Country
  • AIMD United States
  • BHAT China
  • Employees
  • AIMD N/A
  • BHAT N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • BHAT Recreational Games/Products/Toys
  • Sector
  • AIMD Health Care
  • BHAT Consumer Discretionary
  • Exchange
  • AIMD Nasdaq
  • BHAT Nasdaq
  • Market Cap
  • AIMD 8.2M
  • BHAT 8.6M
  • IPO Year
  • AIMD N/A
  • BHAT 2019
  • Fundamental
  • Price
  • AIMD $0.61
  • BHAT $0.05
  • Analyst Decision
  • AIMD
  • BHAT
  • Analyst Count
  • AIMD 0
  • BHAT 0
  • Target Price
  • AIMD N/A
  • BHAT N/A
  • AVG Volume (30 Days)
  • AIMD 1.6M
  • BHAT 123.6M
  • Earning Date
  • AIMD 03-07-2025
  • BHAT 12-23-2024
  • Dividend Yield
  • AIMD N/A
  • BHAT N/A
  • EPS Growth
  • AIMD N/A
  • BHAT N/A
  • EPS
  • AIMD N/A
  • BHAT N/A
  • Revenue
  • AIMD $40,633.00
  • BHAT $40,461,026.00
  • Revenue This Year
  • AIMD N/A
  • BHAT N/A
  • Revenue Next Year
  • AIMD N/A
  • BHAT N/A
  • P/E Ratio
  • AIMD N/A
  • BHAT N/A
  • Revenue Growth
  • AIMD N/A
  • BHAT N/A
  • 52 Week Low
  • AIMD $0.40
  • BHAT $0.04
  • 52 Week High
  • AIMD $3.10
  • BHAT $1.45
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 48.16
  • BHAT 37.33
  • Support Level
  • AIMD $0.61
  • BHAT $0.04
  • Resistance Level
  • AIMD $0.87
  • BHAT $0.06
  • Average True Range (ATR)
  • AIMD 0.09
  • BHAT 0.01
  • MACD
  • AIMD -0.02
  • BHAT 0.00
  • Stochastic Oscillator
  • AIMD 17.50
  • BHAT 33.16

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.

Share on Social Networks: